Login
  • Therapeutic Area
    • Metabolic
  • Resources
  • Contact
Login

  • Add
  • simple. every. day
     
     

    DPP4i – What efficacy to expect?

     

    04/03/2020

    Author: Boehringer Ingelheim

    Related content

    Are your T2D patients on the right DPP4i dose?

    00:48

    Are your T2D patients on the right DPP4i dose?
    DPP4i - Proven efficacy with no dose reduction

    00:38

    DPP4i - Proven efficacy with no dose reduction
    Efficacy, Safety, Simplicity all in one DPP4i

    00:54

    Efficacy, Safety, Simplicity all in one DPP4i
    JENTADUETO® dosing information

    01:22

    JENTADUETO® dosing information
    Renally impaired patients - Are they on the right dose?

    00:38

    Renally impaired patients - Are they on the right dose?
    Restricting TRAJENTA® to only renally impaired patients

    00:21

    Restricting TRAJENTA® to only renally impaired patients
    Production date: March 2020
    Close ×
    • Therapeutic Area
    • Metabolic
    • Resources
    • Videos
    • Clinical studies
    • Site map
    • Terms of use
    • Privacy
    • Contact
    • Change country

    © 2010-2026
    Boehringer Ingelheim International GmbH.
    All rights reserved.